Cargando…

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia

OBJECTIVES: Ultrasound of temporal and axillary arteries may reveal vessel wall inflammation in patients with giant cell arteritis (GCA). We developed a ultrasound scoring system to quantify the extent of vascular inflammation and investigated its diagnostic accuracy and association with clinical fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Geest, Kornelis S M, Borg, Frances, Kayani, Abdul, Paap, Davy, Gondo, Prisca, Schmidt, Wolfgang, Luqmani, Raashid Ahmed, Dasgupta, Bhaskar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Imaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034352/ https://www.ncbi.nlm.nih.gov/pubmed/31900304 http://dx.doi.org/10.1136/annrheumdis-2019-216343

Ejemplares similares

Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Halo score (temporal artery, its branches and axillary artery) as a diagnostic, prognostic and disease monitoring tool for Giant Cell Arteritis (GCA)
por: Sebastian, Alwin, et al.
Publicado: (2020)

Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis
por: Sebastian, Alwin, et al.
Publicado: (2021)

Updates on the diagnosis and monitoring of giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2023)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
por: Schmidt, Wolfgang A., et al.
Publicado: (2020)

Need and value of targeted immunosuppressive therapy in giant cell arteritis
por: Sandovici, Maria, et al.
Publicado: (2022)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?
por: Goodfellow, Nicola, et al.
Publicado: (2017)

Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool
por: Sebastian, Alwin, et al.
Publicado: (2020)

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
por: van Sleen, Yannick, et al.
Publicado: (2017)

Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis
por: Rondaan, Christien, et al.
Publicado: (2017)

Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018)

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies
por: Wang, Lihui, et al.
Publicado: (2020)

Ocular Syphilis Mimicking Giant Cell Arteritis
por: Qadir, Areebah, et al.
Publicado: (2022)

Diagnostic Accuracy of Symptoms, Physical Signs, and Laboratory Tests for Giant Cell Arteritis: A Systematic Review and Meta-analysis
por: van der Geest, Kornelis S. M., et al.
Publicado: (2020)

Impact of cardiovascular risk on the diagnostic accuracy of the ultrasound Halo Score for giant cell arteritis
por: Molina-Collada, Juan, et al.
Publicado: (2022)

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
por: Monjo-Henry, Irene, et al.
Publicado: (2023)

Response to ‘Comment on: ‘A new era for giant cell arteritis’’
por: Mollan, S. P., et al.
Publicado: (2019)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
por: Águeda, Ana F, et al.
Publicado: (2019)

Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013)

Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
por: Esperança Almeida, Diogo, et al.
Publicado: (2023)

Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
por: Monti, Sara, et al.
Publicado: (2019)

Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2019)

European Headache Federation recommendations for neurologists managing giant cell arteritis
por: Mollan, S. P., et al.
Publicado: (2020)

Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis
por: van Sleen, Yannick, et al.
Publicado: (2019)

Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
por: van der Geest, Kornelis S. M., et al.
Publicado: (2022)

Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?
por: van der Geest, Kornelis S. M., et al.
Publicado: (2018)

Ocular Complications of Giant Cell Arteritis: An Acute Therapeutic Emergency
por: Héron, Emmanuel, et al.
Publicado: (2022)

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Esen, Idil, et al.
Publicado: (2021)

Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization
por: Stellingwerff, Menno D., et al.
Publicado: (2015)

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective
por: Mackie, Sarah L, et al.
Publicado: (2021)

O31 Giant cell arteritis - a rare ocular presentation
por: Kulkarni, Priti, et al.
Publicado: (2021)

Phenotypic, transcriptomic and functional profiling reveal reduced activation thresholds of CD8(+) T cells in giant cell arteritis
por: Reitsema, Rosanne D, et al.
Publicado: (2022)

Giant-cell Arteritis of the Ovarian Arteries: A Rare Manifestation of a Common Disease
por: Theunissen, Prisca, et al.
Publicado: (2018)

Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
por: van Sleen, Yannick, et al.
Publicado: (2022)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

33. A case of ocular ischaemic syndrome caused by severe giant cell arteritis
por: Onac, Ioana, et al.
Publicado: (2019)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b58hskser5ioi9fmqu0evcpti7